Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

16.32
+0.32002.00%
Post-market: 16.00-0.3200-1.96%19:30 EDT
Volume:6.49M
Turnover:105.62M
Market Cap:18.75B
PE:-46.06
High:16.37
Open:16.01
Low:15.98
Close:16.00
52wk High:18.39
52wk Low:9.43
Shares:1.15B
Float Shares:1.14B
Volume Ratio:0.90
T/O Rate:0.57%
Dividend:0.48
Dividend Rate:2.94%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.31
PE(LYR):-5.44

Loading ...

Viatris Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Jun 10

Noveris Health Sciences appoints Geoff Griffiths as strategic advisor

Reuters
·
Jun 09

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viatris (VTRS), Medtronic (MDT) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jun 04

Salesforce says Viatris selects Agentforce Life Sciences as global customer engagement platform

Reuters
·
Jun 02

Viatris Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

Viatris Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
May 29

Argus Raises Viatris Price Target to $18 From $15

MT Newswires Live
·
May 28

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 27

Viatris Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
May 23

Viatris Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
May 21

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 20

Viatris Is Maintained at Overweight by Barclays

Dow Jones
·
May 19

Barclays Adjusts Price Target on Viatris to $22 From $17, Maintains Overweight Rating

MT Newswires Live
·
May 19

Viatris price target raised to $22 from $17 at Barclays

TIPRANKS
·
May 19

Barclays Remains a Buy on Viatris (VTRS)

TIPRANKS
·
May 19

FDA accepts Viatris fast-acting meloxicam NDA for acute pain review

Reuters
·
May 18

U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain

THOMSON REUTERS
·
May 18

Viatris Inc - FDA Sets Pdufa Goal Date of Dec. 27, 2026 for Viatris Fast-Acting Meloxicam

THOMSON REUTERS
·
May 18

Viatris Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
May 16